News & Announcements
Assistant Dean at Temple University School of Medicine Selected One of Region's Most Influential Latinos
Raul A. DeLa Cadena, MD, Assistant Dean and Director of the Recruitment, Admissions and Retention (RAR) Program at Temple University School of Medicine, has been selected as one of the "Delaware Valley's Most Influential Latinos" for 2012. He was selected for the honor by the Most Influential Latinos Foundation, whose stated mission is to support and encourage Latino leadership and empowerment. Dr. DeLa Cadena will be recognized, along with the other honorees, at a Gala Dinner and celebration on November 29 in Philadelphia.
"This is a great honor for which I am pleased to be recognized," said Dr. DeLa Cadena. "It is also a reflection on Temple University School of Medicine's proud legacy of helping disadvantaged students overcome academic and economic obstacles that contribute to their underrepresentation among our nation's physicians."
As Director of Temple's RAR Program, Dr. DeLa Cadena works to enhance the recruitment of underrepresented minorities to the School of Medicine. The primary purpose of the RAR Program is to help Temple identify, enroll, retain and graduate physicians from such backgrounds to infuse diversity into the healthcare workforce in the profession of medicine both regionally and nationally.
"This selection of Dr. DeLa Cadena as one of the region's most influential Latinos is well deserved," said Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine. "Dr. DeLa Cadena works tirelessly to help Temple actualize its commitment to diversity in its student body, while also maintaining excellence in its academic programs."
Dr. DeLa Cadena also serves as Professor of Physiology and holds a faculty appointment at Temple's Sol Sherry Thrombosis Research Center. His research focuses on the pathophysiology of Diabetic Retinopathy and Rheumatoid Arthritis.
Date Published: Wednesday, November 21, 2012
back | view all news
Region's First Surgery Using da Vinci® XI™ Surgical Robot Performed at Temple University Hospital
Temple University Hospital has performed the Philadelphia region's first surgery using the new da Vinci® Xi™ Surgical System.
read more »
Research Led by Temple's Chair of Dermatology Shows that Pain and Itch May Be Signs of Skin Cancer
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology at Temple University School of Medicine.
read more »
Temple University Hospital Now Providing Innovative New Option for Patients with Thoracic Aortic Aneurysms
Temple University Hospital is the first hospital in Pennsylvania to offer an innovative procedure that improves long-term outcomes for patients undergoing endovascular repair of thoracic aortic aneurysms (TEVAR).
read more »